Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial

NCT06679855 is registered in ClinicalTrials.gov with NICHD Neonatal Research Network as lead sponsor.

NCT NCT06679855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06679855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial
Lead sponsor
NICHD Neonatal Research Network
Phase
Phase 3
Overall status
Recruiting
Start date
June 13, 2025
Completion date
June 30, 2029
Enrollment
316 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

post-ligation cardiac syndrome